Cargando…
Novel (175)Yb-Poly (L-Lactic Acid) Microspheres for Transarterial Radioembolization of Unrespectable Hepatocellular Carcinoma
Novel biodegradable Poly (L-lactic acid) (PLLA) microspheres containing ytterbium were designed for intra-tumoral radiotherapy, especially for radioembolization. (175)Yb possess both therapeutic beta and diagnostic gamma radiations. In this work, a process of making ready radiomicrospheres (175)Yb (...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Shaheed Beheshti University of Medical Sciences
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6706703/ https://www.ncbi.nlm.nih.gov/pubmed/31531042 http://dx.doi.org/10.22037/ijpr.2019.1100668 |
Sumario: | Novel biodegradable Poly (L-lactic acid) (PLLA) microspheres containing ytterbium were designed for intra-tumoral radiotherapy, especially for radioembolization. (175)Yb possess both therapeutic beta and diagnostic gamma radiations. In this work, a process of making ready radiomicrospheres (175)Yb (acac)(3)-loaded PLLA for more consideration has been investigated. The radiomicrospheres were prepared with approximate size of 20-40 µm, and radionuclidic purity > 92%. The radiomicrospheres were stable in-vitro for up to 72 h in normal saline, and also in human serum albumin (HSA). Biodistribution in mice bearing 4T1 tumor showed specific radionuclide uptake over 48 h. Tumor necrosis was also observed at the injection site up to 12 days after injection. These data indicated that (175)Yb-PLLA microspheres could be prepared and considered further for radiomicrospheres tumor therapy. |
---|